New program aims to boost kidney treatment in diabetes patients

NCT ID NCT06906640

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing an education program for people with type 2 diabetes who also have chronic kidney disease. The program provides patients with information about their kidney health and suggests medications that could slow kidney damage. Researchers will see if this approach helps more patients get the right treatments. The study involves 420 adults receiving primary care in the U.S.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Education program and guideline-directed medical therapy (GDMT) recommendations
What this could lead to
If successful, this program could help more people with diabetes and kidney disease receive the right medications to slow kidney damage.
What could go wrong
This is an implementation study, not a test of new drugs. It may not show clear health improvements, and results depend on patients and doctors following recommendations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (CKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Baylor Scott & White

    RECRUITING

    Temple, Texas, 76508, United States

  • Duke University

    RECRUITING

    Durham, North Carolina, 27707, United States

  • Essentia Institute of Rural Health

    RECRUITING

    Duluth, Minnesota, 55805, United States

  • Houston Methodist

    RECRUITING

    Houston, Texas, 77030, United States

  • Orlando Health

    RECRUITING

    St. Petersburg, Florida, 33701, United States

  • University of Alabama

    RECRUITING

    Birmingham, Alabama, 35233, United States

  • University of Michigan

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.